Generate a tailored SOP for Dr. Jason Cheng. Improve your application with a focused, well-structured draft.
Dr. Jason X. Cheng is an Associate Professor in the Department of Pathology at the University of Chicago, specializing in hematologic diseases, particularly myelodysplastic syndromes (MDS), acute myeloid leukemia (AML), and other hematological malignancies. He has a robust academic background with a focus on chromatin structure and drug resistance, contributing significantly to the fields of hematopathology and cancer biology. Dr. Cheng's research involves RNA epigenetics, particularly the roles of RNA:m5C methyltransferases (NSUN1 and NSUN2) in leukemia and their potential as targets for drug development. He holds several notable awards including the Cancer Research Foundation Young Investigator Award and has conducted pioneering work in identifying sequence-specific DNA-binding peptides for gene editing. Dr. Cheng's collaborations include work with Argonne National Laboratory on artificial intelligence-assisted drug discovery. He is dedicated to advancing the understanding and treatment of hematological malignancies through innovative research and clinical practice.
University of Chicago • Chicago, IL
Teaching and conducting research in the field of Pathology.
University of Chicago • Chicago, IL
Clinical training in Hematopathology under Dr. James Vardiman.
Department of Philosophy